Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine anterior serratus plane block for analgesia in multiple rib fractures
ChiCTR2300079123Phase 4Not yet recruiting
- Sponsor
- Zhangjiagang First People's Hospital
- Start
- Dec 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of liposomal bupivacaine, ropivacaine and lidocaine in multiple rib fractures (5 arms), sponsored by Zhangjiagang First People's Hospital. Primary endpoint: VAS pain score. Planned start Dec 2023; status: not yet recruiting.
02
Drugs
liposomal bupivacaineropivacainelidocaine
03
Conditions
multiple rib fractures
Beyond the preview
Go deeper on ChiCTR2300079123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300079123.